Genetic Approaches to Coronary Heart Disease

Journal of the American College of Cardiology

Volumn 48, Issue 9 SUPPL., 2006, Pages

  Cohen, Jonathan C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA SEQUENCE; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PROCEDURES; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MISSENSE MUTATION; PRIORITY JOURNAL; RELIABILITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 33750445938     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.06.046     Document Type: Review

References (46)

1. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 44 (2004) 720-732
2. Adult Treatment Panel III. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
3. Lusis A.J., Mar R., and Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 5 (2004) 189-218
4. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
5. Nasir K., Michos E.D., Rumberger J.A., et al. Coronary artery calcification and family history of premature coronary heart disease: sibling history is more strongly associated than parental history. Circulation 110 (2004) 2150-2156
6. Snowden C.B., McNamara P.M., Garrison R.J., Feinleib M., Kannel W.B., and Epstein F.H. Predicting coronary heart disease in siblings-a multivariate assessment: the Framingham Heart Study. Am J Epidemiol 115 (1982) 217-222
7. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
8. Livingston R.J., von Niederhausern A., Jegga A.G., et al. Pattern of sequence variation across 213 environmental response genes. Genome Res 14 (2004) 1821-1831
9. Carlson C.S., Eberle M.A., Kruglyak L., and Nickerson D.A. Mapping complex disease loci in whole-genome association studies. Nature 429 (2004) 446-452
10. Harrap S.B., Zammit K.S., Wong Z.Y., et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol 22 (2002) 874-878
11. Francke S., Manraj M., Lacquemant C., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritanians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 10 (2001) 2751-2765
12. Broeckel U., Hengstenberg C., Mayer B., et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 30 (2002) 210-214
13. Hauser E.R., Crossman D.C., Granger C.B., et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 75 (2004) 436-447
14. Pajukanta P., Cargill M., Viitanen L., et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 67 (2000) 1481-1493
15. Wang Q., Rao S., Shen G.Q., et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet 74 (2004) 262-271
16. Chiodini B.D., and Lewis C.M. Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Arterioscler Thromb Vasc Biol 23 (2003) 1863-1868
17. Wang L., Fan C., Topol S.E., Topol E.J., and Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302 (2003) 1578-1581
18. Bhagavatula M.R., Fan C., Shen G.Q., et al. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet 13 (2004) 3181-3188
19. Weng L., Kavaslar N., Ustaszewska A., et al. Lack of MEF2A mutations in coronary artery disease. J Clin Invest 115 (2005) 1016-1020
20. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
21. Heller M.J. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng 4 (2002) 129-153
22. Taillon-Miller P., Saccone S.F., Saccone N.L., et al. Linkage disequilibrium maps constructed with common SNPs are useful for first-pass disease association screens. Genomics 84 (2004) 899-912
23. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
24. Ke X., Hunt S., Tapper W., et al. The impact of SNP density on fine-scale patterns of linkage disequilibrium. Hum Mol Genet 13 (2004) 577-588
25. Hinds D.A., Stuve L.L., Nilsen G.B., et al. Whole-genome patterns of common DNA variation in three human populations. Science 307 (2005) 1072-1079
26. Curran-Everett D. Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol 279 (2000) R1-R8
27. Weller J.I., Song J.Z., Heyen D.W., Lewin H.A., and Ron M. A new approach to the problem of multiple comparisons in the genetic dissection of complex traits. Genetics 150 (1998) 1699-1706
28. Sabatti C., Service S., and Freimer N. False discovery rate in linkage and association genome screens for complex disorders. Genetics 164 (2003) 829-833
29. Satagopan J.M., and Elston R.C. Optimal two-stage genotyping in population-based association studies. Genet Epidemiol 25 (2003) 149-157
30. Satagopan J.M., Venkatraman E.S., and Begg C.B. Two-stage designs for gene-disease association studies with sample size constraints. Biometrics 60 (2004) 589-597
31. Satagopan J.M., Verbel D.A., Venkatraman E.S., Offit K.E., and Begg C.B. Two-stage designs for gene-disease association studies. Biometrics 58 (2002) 163-170
32. Saito A., and Kamatani N. Strategies for genome-wide association studies: optimization of study designs by the stepwise focusing method. J Hum Genet 47 (2002) 360-365
33. Goldstein D.B., and Chikhi L. Human migrations and population structure: what we know and why it matters. Annu Rev Genomics Hum Genet 3 (2002) 129-152
34. Marchini J., Cardon L.R., Phillips M.S., and Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 36 (2004) 512-517
35. Wacholder S., Rothman N., and Caporaso N. Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 11 (2002) 513-520
36. Pritchard J.K., and Donnelly P. Case-control studies of association in structured or admixed populations. Theor Popul Biol 60 (2001) 227-237
37. Devlin B., and Roeder K. Genomic control for association studies. Biometrics 55 (1999) 997-1004
38. Hinds D.A., Stokowski R.P., Patil N., et al. Matching strategies for genetic association studies in structured populations. Am J Hum Genet 74 (2004) 317-325
39. Wang W.Y., Barratt B.J., Clayton D.G., and Todd J.A. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 6 (2005) 109-118
40. Thomas D.C., Haile R.W., and Duggan D. Recent developments in genomewide association scans: a workshop summary and review. Am J Hum Genet 77 (2005) 337-345
41. Shiffman D., Ellis S.G., Rowland C.M., et al. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 77 (2005) 596-605
42. Cohen J.C., Kiss R.S., Pertsemlidis A., Marcel Y.L., McPherson R., and Hobbs H.H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
43. Cohen J., Pertsemlidis A., Kotowski I.K., Graham R., Garcia C.K., and Hobbs H.H. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 37 (2005) 161-165
44. Cohen J., Pertsemlidis A., Fahmi S., et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proceed Natl Acad Sci U S A 103 (2006) 1810-1815
45. Kotowski I.K., Pertsemlidis A., Luke A., et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J of Hum Genet 78 (2006) 410-422
46. Cohen J.C., Boerwinkle E., Mosley Jr. T.H., and Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354 (2006) 34-42